People: Cyberonics, Inc. (CYBX.O)

CYBX.O on Consolidated Issue listed on NASDAQ Global Market

17.60USD
9 Feb 2010
Price Change (% chg)

$0.23 (+1.32%)
Prev Close
$17.60
Open
--
Day's High
$17.63
Day's Low
$17.31
Volume
190,554
Avg. Vol
156,305
52-wk High
$21.63
52-wk Low
$12.31

view people for:

Summary

Name Age Since Current Position
Moore, Daniel 48 2007 President, Chief Executive Officer, Director
Browne, Gregory 56 2007 Chief Financial Officer, Vice President - Finance
Simpson, Randal 49 2009 Vice President - Operations
Wise, David 54 2009 Vice President of Human Resources, General Counsel, Secretary
Reinstein, James 44 2007 Vice President - Sales and Marketing, General Manager - International
Olin, Bryan 42 2009 Vice President - Quality
Morris, Milton 39 2009 Vice President - Research & Development
Terry, Reese 67 2007 Director
Jackson, Guy 67 2003 Director
Morrison, Hugh 62 2006 Director
Novak, Alfred 61 2007 Director
Rosenthal, Arthur 62 2007 Director
Laptewicz, Joseph 60 2008 Director
» Insider Trading

Biographies

Name Description
Moore, Daniel Mr. Daniel J. Moore is the President, Chief Executive Officer, Director of Cyberonics, Inc. He has been appointed to the Board of Cyberonics, Inc. in May 2007. Contemporaneous with his appointment to the Board, Mr. Moore was appointed by the Board as President and Chief Executive Officer. Mr. Moore joined the company from Boston Scientific Corporation (“Boston Scientific”), a diverse maker of minimally invasive medical products, where, since 1989, he held positions in sales, marketing, and senior management in the United States and in Europe. His last position at Boston Scientific was President, International Distributor Management. Prior to that role, he held the position of President, Inter-Continental, the fourth largest business unit of Boston Scientific, with more than 1,000 global employees and revenues exceeding $700.0 million. Mr. Moore previously held senior management positions at several Boston Scientific U.S. and international divisions.
Browne, Gregory Mr. Gregory H. Browne is Vice President, Finance and Chief Financial Officer of Cyberonics, Inc. Mr. Browne has served as both Chief Executive Officer and Chief Financial Officer for several publicly traded healthcare companies. From May 2002 to June 2006, he was Chief Financial Officer at Amedisys, Inc., a home nursing company with revenues in excess of $600.0 million, during a period of substantial growth in revenue, profitability and market capitalization. From June 2006 to November 2006, Mr. Browne was a private investor, and from November 2006 to July 2007, he was a partner with Tatum, LLC, an executive services company. Prior to May 2002, he served as Chief Executive Officer for Ramsay Healthcare Inc., a provider of psychiatric services, and Ramsay-HMO, Inc., a health maintenance organization, and also founded and served as President at PeopleWorks, Inc, a human resource outsourcing company.
Simpson, Randal Mr. Randal L. Simpson is Vice President, Operations of Cyberonics, Inc. Mr. Simpson joined the company in 1998 and served in various manufacturing management positions such as Director, Manufacturing, Director, Materials, and Sr. Director of Operations, until October 2003 when he became Vice President, Operations. From March 2006 until May 2008, Mr. Simpson was responsible for Quality, and from August 2007 until January 2009, he also assumed responsibility for Research and Development. From February to May 2009, he again assumed responsibility for Quality. Prior to joining the company, Mr. Simpson was employed by Intermedics, Inc., a manufacturer of implantable medical devices for cardiac rhythm management, including pacemakers and defibrillators, as Manager of Manufacturing. Mr. Simpson has more than 25 years of manufacturing experience with more than 18 years of experience in the medical device industry.
Wise, David Mr. David S. Wise is Vice President of Human Resources, General Counsel, Secretary of Cyberonics, Inc. Mr. David S. Wise joined the company in September 2003 as Vice President and General Counsel. He was appointed as Secretary in November 2003. From July 1994 to September 2003, Mr. Wise was employed at Centerpulse USA Inc. (formerly Sulzer Medica USA Inc.), a medical technology company specializing in orthopedic products acquired by Zimmer Holdings, Inc. in 2003, serving as Group Vice President and General Counsel from September 1998 to September 2003. Prior to July 1994, he spent 12 years in private legal practice focused on intellectual property and commercial litigation. Mr. Wise has more than 26 years of experience in intellectual property, business development and legal affairs in private practice and in corporate practice in the medical device industry.
Reinstein, James Mr. James A. Reinstein is Vice President - Sales and Marketing, General Manager - International of Cyberonics, Inc., after a 17-year career at Boston Scientific Corporation, where he held positions in sales, marketing, and general management in the United States, Europe, Latin America, and Asia. From 2005 through mid 2007, he served as Vice President of Asia with direct leadership of Korea, Taiwan, and Hong Kong. Prior to that role, he was the Country Director of Boston Scientific de Mexico, where the business experienced compounded annual growth in excess of 30%. Countries under his leadership were recognized for excellence relative to peer countries in four of his last six years, with Korea being recognized as the top international country in 2006. Additionally, Mr. Reinstein held senior management positions at several Boston Scientific U.S. and international divisions. Prior to joining Boston Scientific, he spent four years with The Procter & Gamble Company in sales and management roles.
Olin, Bryan Dr. Bryan D. Olin, Ph.D., is Vice President - Quality of Cyberonics, Inc., after leaving Zeltiq Aesthetics, Inc., a privately held medical technology company in the San Francisco Bay Area, where he had served as Sr. Director, Quality Assurance since October 2007. Prior to Zeltiq Aesthetics, Dr. Olin was employed at the LifeScan and Cordis franchises of Johnson & Johnson from 1999 to 2007, holding several positions of increasing responsibility in quality assurance, statistics, and clinical data management. Dr. Olin began his career with Procter & Gamble in 1993 after obtaining his Ph.D. in Statistics from Iowa State University. In July 2009, he assumed the role of Interim Vice President, Clinical Affairs.
Morris, Milton Dr. Milton M. Morris, Ph.D., is Vice President - Research and Development of Cyberonics, Inc., from Innerpulse Corporation, a private company developing an implantable defibrillator, where he had been the Director, Program Management & Operations since July 2007. Prior to Innerpulse, he spent 11 years at Boston Scientific and its predecessor, Guidant Corporation, where he served as Director, Marketing from May 2006 to July 2007, Field Clinical Representative from October 2004 to May 2006, Director, Research & Development from November 2002 to October 2004, and Manager, Research & Development from October 1999 to October 2002. Dr. Morris received his PhD. in Electrical Engineering from The University of Michigan.
Terry, Reese Mr. Reese S. Terry, Jr. is member of the Board of Cyberonics, Inc. since December 1987 when he co-founded Cyberonics and served as Chairman of the Board and Chief Executive Officer until February 1990, when he became Chairman of the company's Board and Executive Vice President. He also served as Chief Executive Officer for a portion of 1995. Mr. Terry resigned from his position as Executive Vice President in February 2000 and from his positions as Chairman of the Board and Secretary in June 2001. Since 2001, other than the period from November 2006 to May 2007, when he served as the Chief Executive Officer on an interim basis while the company's Board conducted a search for a new Chief Executive Officer, Mr. Terry has been an independent business consultant to and an investor in the company. Mr. Terry has consulted for the compnay on technical matters from September 2005 to November 2006 and from May 2007 to the present. From 1976 to 1986, Mr. Terry held executive positions with Intermedics, Inc., a medical device and electronics company, including serving as Vice President of Engineering, Vice President of Corporate Technical Resources and Vice President of Quality. Mr. Terry serves on the board of directors of the Epilepsy Foundation, a national organization that works for people affected by seizures through research, education, advocacy, and service. Mr. Terry also serves on the board of directors of IDEV, a privately-held company in the cardiovascular device field.
Jackson, Guy Mr. Guy C. Jackson has been a member of the Board of Cyberonics, Inc. since July 2003. In June 2003, Mr. Jackson retired from the accounting firm of Ernst & Young LLP after 35 years with the firm and one of its predecessors, Arthur Young & Company. During his career, Mr. Jackson served as the audit partner for a number of public companies in Ernst & Young’s New York and Minneapolis offices. Mr. Jackson has a Bachelor of Science degree from The Pennsylvania State University and a Masters of Business Administration from the Harvard Business School. Mr. Jackson also serves on the board of directors and is chairman of the audit committees of Digi International, Inc., a technology company, EpiCept Corporation, a specialty pharmaceutical company, Life Time Fitness, Inc., an operator of fitness centers, and Urologix, Inc., a medical device company.
Morrison, Hugh Mr. Hugh M. Morrison has been appointed to the Board of Cyberonics, Inc. in November 2006. From 1983 to December 2005, Mr. Morrison served as a director, and from January 1998 to December 2005 as Chairman of the board of directors, of Advanced Neuromodulation Systems, Inc., a publicly-held designer, developer, manufacturer, and marketer of advanced implantable neuromodulation devices. In December 2005, Advanced Neuromodulation Systems, Inc. was sold to St. Jude Medical, Inc. Mr. Morrison served as a director of Owen Healthcare, Inc., a publicly held hospital pharmacy management firm, from 1994 until it was acquired in 1996 by Cardinal Healthcare. In addition, Mr. Morrison served as a director of Dow Hickam Pharmaceuticals, Inc., a pharmaceutical manufacturer and marketer, from 1984 to 1991, when the company was sold to Mylan Laboratories, Inc. From March 1996 to May 2006, Mr. Morrison served as President and Chief Executive Officer, and from January 1998 to May 2006 as Chairman of the board of directors, of Pilgrim Cleaners, Inc., a retail dry cleaning company operating over 100 stores (“Pilgrim”), and its parent, Clean Acquisition, Inc. (“Clean”). In January 2004, Pilgrim and Clean each filed a petition under Chapter 11 of the Bankruptcy Code with the United States Bankruptcy Court for the Southern District of Texas, Houston Division. Subsequent to Mr. Morrison’s resignation, Pilgrim and Clean each filed a petition under Chapter 7 of the Bankruptcy Code with the United States Bankruptcy Court for the Southern District of Texas, Houston Division in July 2006. Mr. Morrison is licensed as a Certified Public Accountant.
Novak, Alfred Mr. Alfred J. Novak has been appointed to the Board of Cyberonics, Inc. in January 2007. Since September 1999, Mr. Novak has served on the board of directors of OrbusNeich Medical Technology Company, Ltd., a privately held interventional cardiology company, where he was named Vice Chairman and Chief Executive Officer in February 2008 and more recently President and Chief Executive Officer. Since December 1997, he has been the Chairman of the board of directors of ProRhythm, Inc., a company dedicated to the treatment of atrial fibrillation through the use of ultrasound technologies. In September 1998, he was a founder of Syntheon, LLC, a privately-held company that focuses on minimally invasive medical devices for the gastroenterology and vascular markets. From October 2002 until March 2006, Mr. Novak was the President and Chief Executive Officer and director of Novoste Corporation, a publicly-held interventional cardiology company. From December 1998 until October 2002, Mr. Novak was a member of the board of directors of Sutura, Inc., a vascular closure company. Mr. Novak was President, Chief Executive Officer, and a director of Biosense, Inc., an electrophysiology company, from July 1996 until January 1998. He was employed by Cordis Corporation, a publicly-held cardiology company, from April 1984 until July 1996 and served as its Vice President and Chief Financial Officer.
Rosenthal, Arthur Dr. Arthur L. Rosenthal, Ph.D is appointed to the Board of Cyberonics, Inc. in January 2007. He served as Chairman commencing in January 2002, and Chief Executive Officer commencing in January 2005, of Labcoat, Ltd. until its acquisition by Boston Scientific in December 2008. He was a Senior Vice President, Corporate Officer, and Chief Development Officer of Boston Scientific and from January 1994 though May 2000, he was a Senior Vice President, Chief Scientific Officer, and Executive Committee Member of Boston Scientific until his retirement in January 2005. Dr. Rosenthal currently serves as a non-executive director and Chairman of the Remuneration Committee for Renovo, Ltd., a U.K. publicly-traded pharmaceutical company.
Laptewicz, Joseph Mr. Joseph E. Laptewicz, Jr. has been a member of Cyberonics, Inc., Board since September 2008. Mr. Laptewicz is a retired business executive with extensive medical device experience. From 1998 to 2005, he served on the board of directors of Advanced Neuromodulation Systems, Inc., a publicly-held manufacturer of implantable neuromodulation devices for the treatment of pain. From 1996 to 2003, he served on the board of directors of AngioDynamics, Inc., a publicly-held manufacturer of interventional radiology products. From 1994 to 2000, Mr. Laptewicz served as President and Chief Executive Officer, and from 2001 to 2004 as Chairman of the board of directors, of Empi, Inc., a manufacturer and provider of non-invasive medical products for pain management and physical rehabilitation. From 1972 to 1994, Mr. Laptewicz served in various positions of increasing responsibility for subsidiaries of Pfizer, Inc., at the time a large pharmaceutical and medical technology company, including Vice President and General Manager from 1990 to 1991 and President from 1991 to 1994 of Schneider (USA), Inc., a worldwide manufacturer of catheters, stents, and related medical products.

Basic Compensation

Name Fiscal Year Total
Moore, Daniel 2,694,980
Browne, Gregory 923,655
Simpson, Randal 828,884
Wise, David 1,001,330
Reinstein, James 1,279,040
Olin, Bryan --
Morris, Milton --
Terry, Reese 249,711
Jackson, Guy --
Morrison, Hugh --
Novak, Alfred --
Rosenthal, Arthur --
Laptewicz, Joseph --
As Of 23 Apr 2009

Options Compensation

Name Options Value
Moore, Daniel 56,250 765,312
Browne, Gregory 15,000 270,675
Simpson, Randal 4,750 97,418
Wise, David 191,083 425,079
Reinstein, James 25,000 484,750
Olin, Bryan 0 0
Morris, Milton 0 0
Terry, Reese 54,500 604,594
Jackson, Guy 0 0
Morrison, Hugh 0 0
Novak, Alfred 0 0
Rosenthal, Arthur 0 0
Laptewicz, Joseph 0 0

Insider Trading

Name Shares Traded Price
TERRY REESE S JR 400 $0.00
TERRY REESE S JR 2,000 $16.70
OLSEN ALAN JAMES 2,150 $16.05
WISE DAVID S 989 $0.00
SIMPSON RANDAL L 725 $0.00
TERRY REESE S JR 100 $14.55
TERRY REESE S JR 200 $14.51
TERRY REESE S JR 1,900 $14.35
TERRY REESE S JR 201 $14.53
TERRY REESE S JR 899 $14.50
TERRY REESE S JR 500 $14.52
TERRY REESE S JR 100 $14.36
TERRY REESE S JR 100 $14.48
MORRIS MILTON MAYO 6,878 $0.00
BROWNE GREGORY HASWELL 39,547 $0.00
WISE DAVID S 10,394 $0.00
MOORE DANIEL JEFFREY 46,000 $0.00
OLIN BRYAN D 15,000 $0.00
TERRY REESE S JR 5,095 $0.00
JACKSON GUY C 5,095 $0.00
LAPTEWICZ JOSEPH E 5,095 $0.00
REINSTEIN JAMES A 36,840 $0.00
BROWNE GREGORY HASWELL 11,341 $0.00
SIMPSON RANDAL L 8,152 $0.00
NOVAK ALFRED J 5,095 $0.00
» Full list on Insider Trading
view people for: